Companies / NovoCure Ltd
NovoCure Ltd
Nasdaq: NVCRCIK 1645113ST. HELIER
Financials · FY2025
Ownership
116.4M shares outstanding · as of Jul 17, 2026
Ownership
| Institutions | 81.48% | 94,875,298 |
| Public float | 18.52% | 21,570,542 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Ben Arye BarakFormerGeneral Counsel | — | — |
Brackmann ChristophChief Financial Officer | — | — |
Cordova AshleyCEOFormer Chief Executive Officer | — | — |
Danziger AsafDirector | — | — |
Doyle William FExecutive Chairman · Director | — | — |
Hilleman Jeryl LDirector | — | — |
Hung DavidDirector | — | — |
Leonard Frank XCEOFormerChief Executive Officer | — | — |
Leung GabrielDirector | — | — |
Leupin NicolasFormerFormer Chief Medical Officer | — | — |
Institutional holders 247
View all →| Holder | Value | % of shares |
|---|---|---|
| $217.18M | 14.42% | |
| $203.22M | 11.52% | |
| $141.69M | 9.41% | |
| $110.30M | 7.33% | |
| $65.55M | 4.35% | |
| $43.43M | 2.46% | |
| $27.38M | 2.16% | |
| $25.99M | 1.73% | |
| $16.91M | 1.33% | |
| $16.46M | 1.09% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Doyle William F Executive | Sell | Ordinary Shares | $646.4K | -51K -12.63% | 349,727 0.30% of shares | medium |
| Mar 5, 2026 | Paravasthu Mukund Executive | Sell | Ordinary Shares | $595.7K | -43K -37.26% | 72,832 0.06% of shares | medium |
| Mar 3, 2026 | Doyle William F Executive | Sell | Ordinary Shares | $286.4K | -21K -6.10% | 328,397 0.28% of shares | medium |
| Apr 28, 2026 | Vernon W Anthony Director | Exercise | Ordinary Shares | $244.9K | +22K +12.00% | 200,602 0.17% of shares | low |
| Mar 4, 2026 | Cordova Ashley CEO | Other | Ordinary Shares | $234.6K | -18K -4.01% | 422,570 0.36% of shares | low |
| Feb 27, 2026 | Cordova Ashley CEO | Other | Ordinary Shares | $158.7K | -12K -2.64% | 426,028 0.37% of shares | low |
| Feb 27, 2026 | Leonard Frank X CEO | Sell | Ordinary Shares | $133.0K | -10K -2.80% | 338,011 0.29% of shares | medium |
| Feb 27, 2026 | Weinberg Uri Executive | Sell | Ordinary Shares | $103.3K | -7K -3.37% | 213,757 0.18% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Soleus Capital Master Fund, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NVCR | — | G6674U108 |